| Autor: |
Korzeniowska, Katarzyna, Cieślewicz, Artur, Jabłecka, Anna |
| Předmět: |
|
| Zdroj: |
Medical Research Journal (2451-2591); 2024, Vol. 9 Issue 1, p58-64, 7p |
| Abstrakt: |
Introduction: Psychiatric patients are an interesting group due to the risk of mental exacerbation during COVID-19 (coronavirus disease 2019). Most patients with severe mental disorders require long-term care in specialized centres. As a result, such patients are at increased risk of acquiring infectious diseases, including COVID-19. This study evaluated the potential association between mental disorder treatment and the course of COVID-19. Material and methods: The study is a retrospective analysis of data collected from 107 men with mental disorders, aged 30-82 years, inhabitants of nursing homes who have been receiving drugs acting on the central nervous system for at least one year and were diagnosed with COVID-19 between September 2020 and January 2021. Results: More than 80% of patients experienced elevated body temperature during COVID-19. 11 patients required hospitalization due to severe COVID-19 course; one of them died. The most common mental disorder diagnosis included schizophrenia, schizotypal and delusional disorders, and mental retardation. A significantly higher frequency of increased body temperature was observed in patients treated with anxiolytics (particularly in the subgroup who received hydroxyzine treatment). Conclusions: The course of COVID-19 was mild in most patients (almost 90% of the studied population) and did not negatively affect their mental condition. Special care received by the patients resulted in early diagnosis of COVID-19 and a very low mortality rate. Treatment with hydroxyzine significantly influenced the incidence of increased body temperature during the course of COVID-19. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
